A Phase I Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers
Condition: Yellow FeverInterventions: Biological: YF Vax 17D Strain; Drug: ISA-720; Biological: MVA-BN Yellow Fever Vaccine; Other: Placebo; Biological: MVA Smallpox VaccineSponsor: National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified April 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Allergy | Allergy & Immunology | Infectious Diseases | Research | Vaccines | Yellow Fever | Yellow Fever Vaccination